自体软骨细胞再生的可注射软骨微组织用于鼻部填充:5年随访研究
研究纳入28例患者,取约1.0 cm²耳后软骨分离软骨细胞,经高密度接种及含细胞因子(转化生长因子β-1、胰岛素样生长因子-1)的软骨诱导培养基体外培养3周构建自体软骨片,再制成可注射软骨微组织(ICM)注入皮下腔隙行鼻整形。5年随访中83.3%患者满意度为优或良,仅2例(8.3%)出现明显移植物吸收;MRI证实注射部位存在再生组织,组织学显示成熟软骨形成。
要点
- 28例患者均成功制备可注射软骨微组织(ICM),植入后有效抬高鼻背。
- 5年随访中83.3%患者术后满意度为优或良,仅2例(8.3%)出现明显移植物吸收。
- MRI证实注射部位存在再生组织,组织学显示成熟软骨形成并伴典型软骨陷窝。
核心结论
- 结果表明ICM可促进体内稳定的软骨再生与长期维持,其植入可实现鼻背凹陷的自然填充。
研究设计与样本
- 研究纳入28例患者,取约1.0 cm²耳后软骨,分离软骨细胞扩增后经高密度接种及含细胞因子(如转化生长因子β-1和胰岛素样生长因子-1)的软骨诱导培养基体外培养3周构建自体软骨片,再制成ICM注入皮下腔隙行鼻整形。
- 证据等级为治疗性研究,IV级。
主要发现
- 所有患者均成功制备ICM,植入后有效抬高鼻背。
- MRI证实注射部位存在再生组织,组织学检查显示成熟软骨形成,伴典型软骨陷窝及丰富的软骨特异性细胞外基质沉积。
- 5年随访中83.3%的患者术后满意度为优或良。
- 仅2例患者(8.3%)出现明显的移植物吸收。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A lack of ideal filling materials is a critical limitation in current rhinoplasty. Cartilage sheet regeneration by autologous chondrocytes is expected to provide an ideal source of material. However, the inability to perform minimally invasive transplantation of cartilage sheets has greatly limited the clinical application of this material. In this article, the authors propose the concept of injectable cartilage microtissue (ICM) based on cartilage sheet technology, with the aim of achieving minimally invasive augmentation rhinoplasty in clinical practice. METHODS: Approximately 1.0 cm2 of posterior auricular cartilage was collected from 28 patients. Isolated chondrocytes were expanded, then used to construct autologous cartilage sheets by high-density seeding and in vitro culture in chondrogenic medium with cytokines (eg, transforming growth factor beta-1 and insulin-like growth factor-1) for 3 weeks. Next, ICM was prepared by granulation of the cartilage sheets; it was then injected into a subcutaneous pocket for rhinoplasty. RESULTS: ICM was successfully prepared in all patients, and its implantation efficiently raised the nasal dorsum. Magnetic resonance imaging confirmed that regenerative tissue was present at the injection site; histologic examinations demonstrated mature cartilage formation with typical cartilage lacunae and abundant cartilage-specific deposition of extracellular matrix. Excellent or good postoperative patient satisfaction results were achieved in 83.3% of patients over 5 years of follow-up. Obvious absorption of grafts occurred in only two patients (8.3%). CONCLUSIONS: These results demonstrated that ICM could facilitate stable cartilage regeneration and long-term maintenance in the human body; the implantation of ICM enabled natural augmentation of the depressed nasal dorsum. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Li D, Yin Z, Liu Y, et al. Injectable Cartilage Microtissue Regenerated by Autologous Chondrocytes for Nasal Augmentation: A 5-Year Follow-Up Study. Plast Reconstr Surg. 2023. PMID: 38810156. doi:10.1097/PRS.0000000000010604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。